过氧化物酶体增生物激活受体介导的前列环素/前列环素类似物相关药理作用研究进展
摘要
自20世纪70年代发现前列环素(Prostacyclin,PGI2)以来,人们就开始探讨PGI2/PGI2类似物的作用及途径。此前有研究发现,PGI2/PGI2类似物可与其受体(Prostacyclin receptor,IP)结合,激活腺苷酸环化酶(AC),升高环磷腺苷(cAMP),进而激活cAMP依赖性蛋白激酶(PKA),发挥舒张血管、抑制血小板聚集、抑制血管平滑肌细胞增殖和迁移、促进血管平滑肌细胞分化等作用。
出处
《中国药房》
CAS
CSCD
北大核心
2010年第41期3922-3924,共3页
China Pharmacy
参考文献15
-
1Vane JR, Blotting RM. Pharmacodynamic profile of prostacyclin[J]. Am J Cardiol, 1995, 75 (3) : 3A.
-
2Kubis N, Levy BI. Angiogenic effect of prostaglandin I2 in relation with its effect on PPAR nuclear receptors[J]. J Mol Cell Cardiol, 2004, 36(3) : 331.
-
3Spisni E, Griffoni C, Santi S, et al. Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis[J]. Exp Cell Res, 2001, 266(1):31.
-
4Pola R, Gaetani E, Flex A, et al. Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors[J]. J Mol Cell Cardiol, 2004, 36(3) : 363.
-
5Barbara DA .Review of the expression of peroxisome proliferators-activated receptors alpha (PPARα), beta (PP- ARβ), and gamma (PPARy) in rodent and human development[J]. Reprod Toxicol, 2009, 27(3-4) : 246.
-
6Lefebvre P, Chinetti G, Fruchart JC, et al. Sorting out of PPAR ct in energy metabolism and vascular hormeostasis [J]. J Clin Invest, 2006, 116 (3) : 571.
-
7Yue TL, Bao WK, Beat J, et al. Activation ofperoxisome proliferator--activated receptor-alpha protects the heart from ischemia/reperfusion injury[J]. Circulation, 2003, 108(19): 2 393.
-
8Atsuta H, Uchiyama T, Kanai H, et al. Effects of a stable prostacyclin analogue beraprost sodium on VEGF and PAI-1 gene expression in vascular smooth muscle cells [J]. Int J Cardiol, 2009, 132(3): 411.
-
9Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms[J]. Trends Immunol, 2007, 28 (12) : 551.
-
10Fan Y, Wang Y, Tang Z, et al. Suppression of proinflammatory adhesion molecules by PPAR-8 in human vascular endothelial cells[J]. Arterioscler Thromb Vase Biol, 2008, 28(2): 315.
二级参考文献10
-
1Li AC, Binder CJ, Gutierrez A, et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ. J Clin Invest, 2004, 114 : 1564 - 1576.
-
2Lazennec G, Canaple L, Saugy D, et al. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol, 2000, 14 : 1962- 1975.
-
3Rieck M, Wedeken L, Muller-Brusselbach S, et al. Expression level and agonist-binding affect the turnover, nhiqnitination and complex formation of peroxisome proliferator activated receptor-β. FEBS J, 2007, 274 : 5068 -5076.
-
4Tan NS, Michalik L, Noy N, et al. Critical roles of PPARβ in keratinocyte response to inflammation. Genes Dev, 2001, 15 : 3263 - 3277.
-
5aRiserus U, Sprecher D, Johnson T, et al. Activation of PPAR promotes reversal of multiple metabolic abnormalities, reduces oxidative stress and increases fatty acid oxidation in moderately obese men. Diabetes, 2008, 57 : 332 - 339.
-
6Oliver WR, Shenk JL. A selective peroxisome proliferator- activated receptor-β agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA, 2001, 98 : 5306- 5311.
-
7Akiyama TE, Lambert G, Nicol C J, et al. Peroxisome proliferators activated receptor β/δ regulates very low-density lipoprotein production and catabolism in mice on a Western diet. J Biol Chem, 2004, 279 : 20874 -20881.
-
8Fan Y, Wang Y, Tang Z, et al. Suppression of proinflammatory adhesion molecules by PPAR-δ in human vascular endothelial cells. Arterio Thromb Vas Bio, 2008, 28 : 315 -321.
-
9Graham TL, Mookherjee C, Suckling KE, et al. The PPAR- β agonist GW0742X reduces atherosclerosis in LDLR^-/- mice. Atherosclerosis, 2005, 181 : 29 - 37.
-
10Lee CH, Chawla A, Urbiztondo N, et al. Transcriptional repression of atherogenic inflammation : modulation by PPARβ. Science, 2003, 302 : 453 -457.
共引文献3
-
1赵攀,张晓燕,杨吉春,管又飞.PPARβ/δ在炎症中的作用[J].中国药理学通报,2009,25(9):1124-1127. 被引量:7
-
2郑莹莹,徐来祥,徐金会,薛慧良,陈蕾.黑线仓鼠PPARβ部分编码区克隆与结构特征[J].曲阜师范大学学报(自然科学版),2012,38(1):85-90.
-
3曾正英,廖高鸿,吕雅斐,陈国良.PPARs激动剂在心脑血管疾病中的研究进展[J].中国药物化学杂志,2014,24(2):147-156. 被引量:6
-
1ENDOCRINOPHARMACOLOGY[J].中国药理学与毒理学杂志,2009,23(4):264-268.
-
2任月英,吴文.肺动脉高压治疗新药西里帕格的药理作用及临床评价[J].世界临床药物,2017,38(1):64-67. 被引量:2
-
3王鹏,高松源,李文良.过氧化物酶体增生物激活受体激动剂对脑胶质瘤细胞黏附分子表达的抑制作用[J].中华实验外科杂志,2007,24(2):251-251.
-
4赵荫涛,赵春霞,汪培华,汪道文.苯扎贝特对血管平滑肌细胞增殖和迁移的影响[J].中华心血管病杂志,2006,34(3):269-271. 被引量:5
-
5张军,宋亮年.过氧化物酶体增生物激活受体的结构、功能及其生物学意义[J].国外医学(药学分册),1996,23(3):143-147. 被引量:2
-
6杜洋,刘栩晗,郭莲英,沈洁,王晓陶,施广霞.过氧化物酶体增生物激活的受体γ活化对慢性阻塞性肺疾病大鼠肺中性粒细胞趋化因子表达的影响[J].中华结核和呼吸杂志,2005,28(4):274-275. 被引量:4
-
7Ioana R. Preston,崔娜(译),杨媛华(审校).肺动脉高压的当代治疗[J].中华医学杂志,2009,89(30):2095-2096.
-
8杨海华,陈弘群,李善群,余荣环,胡强.过氧化物酶体增殖活化体受体γ与支气管哮喘气道重塑相关细胞[J].国际呼吸杂志,2010,30(17):1058-1062.
-
9杨海华,陈弘群,李善群,余荣环,胡强.过氧化物酶体增殖活化体受体γ与支气管哮喘气道重塑相关细胞[J].中华哮喘杂志(电子版),2010,4(4):215-219.
-
10林志鸿,吴可贵,李庚山,谢良地,许昌声.氟伐他丁对血管损伤后内皮素、血栓素A_2和前列环素的作用[J].福建医科大学学报,2001,35(4):345-347.